Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthy Extracts (HYEX) Return on Sales (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Return on Sales data on record, last reported at 0.5% in Q3 2025.

  • For Q3 2025, Return on Sales fell 62.0% year-over-year to 0.5%; the TTM value through Sep 2025 reached 0.24%, down 14.0%, while the annual FY2024 figure was 0.06%, 84.0% up from the prior year.
  • Return on Sales reached 0.5% in Q3 2025 per HYEX's latest filing, down from 0.11% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.11% in Q3 2024 and bottomed at 3.44% in Q1 2021.
  • Average Return on Sales over 5 years is 0.68%, with a median of 0.43% recorded in 2023.
  • The widest YoY moves for Return on Sales: up 1148bps in 2021, down -77bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 0.75% in 2021, then soared by 68bps to 0.24% in 2022, then crashed by -100bps to 0.48% in 2023, then soared by 48bps to 0.25% in 2024, then plummeted by -99bps to 0.5% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.5% in Q3 2025, 0.11% in Q2 2025, and 0.12% in Q1 2025.